Literature DB >> 20632407

Association of airway cathepsin B and S with inflammation in cystic fibrosis.

S L Martin1, K L Moffitt, A McDowell, C Greenan, R J Bright-Thomas, A M Jones, A K Webb, J S Elborn.   

Abstract

SUMMARY: Irreversible tissue damage within the cystic fibrosis (CF) lung is mediated by proteolytic enzymes during an inflammatory response. Serine proteinases, in particular neutrophil elastase (NE), have been implicated however, members of the cysteine proteinase family may also be involved. The aim of this study was to determine cathepsin B and S levels in cystic fibrosis (CF) sputum and to assess any relationship to recognized markers of inflammation such as sputum NE, interleukin-8 (IL-8), tumor necrosis factor alpha (TNF-alpha), urine TNF receptor 1 (TNFr1), plasma IL-6, and serum C-reactive protein (CRP). Proteinase activities were measured in the sputum of 36 clinically stable CF patients using spectrophotometric and fluorogenic assays. Immunoblots were also used to confirm enzyme activity data. All other parameters were measured by ELISA. Patients had a mean age of 27.2 (8.2) years, FEV. of 1.6 (0.79) L and BMI of 20.7 (2.8). Both cathepsin B and S activities were detected in all samples, with mean concentrations of 18.0 (13.5) microg/ml and 1.6 (0.88) microg/ml, respectively and were found to correlate not only with each other but with NE, TNF-alpha and IL-8 (in all cases . < 0.05). Airway cathepsin B further correlated with circulatory IL-6 and CRP however, no relationship for either cathepsin was observed with urine TNFr1. This data indicates that cathepsin B and S may have important roles in the pathophysiology of CF lung disease and could have potential as markers of inflammation in future studies. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20632407     DOI: 10.1002/ppul.21274

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  18 in total

1.  Cathepsin B contributes to Na+ hyperabsorption in cystic fibrosis airway epithelial cultures.

Authors:  Chong Da Tan; Carey Hobbs; Mansoureh Sameni; Bonnie F Sloane; M Jackson Stutts; Robert Tarran
Journal:  J Physiol       Date:  2014-09-25       Impact factor: 5.182

2.  CrossTalk proposal: mucosal acidification drives early progressive lung disease in cystic fibrosis.

Authors:  Miriam F Figueira; Megan J Webster; Robert Tarran
Journal:  J Physiol       Date:  2018-07-17       Impact factor: 5.182

3.  Treatment with CA-074Me, a Cathepsin B inhibitor, reduces lung interstitial inflammation and fibrosis in a rat model of polymyositis.

Authors:  Li Zhang; Xiao-Hong Fu; Yong Yu; Ruo-Hong Shui; Chun Li; Hai-Ying Zeng; Yu-Lei Qiao; Li-Yan Ni; Qiang Wang
Journal:  Lab Invest       Date:  2014-11-10       Impact factor: 5.662

Review 4.  Overview of positron emission tomography in functional imaging of the lungs for diffuse lung diseases.

Authors:  Avanti V Gulhane; Delphine L Chen
Journal:  Br J Radiol       Date:  2021-11-09       Impact factor: 3.629

Review 5.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

6.  miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production.

Authors:  Sinéad Weldon; Paul McNally; Danny F McAuley; Irene K Oglesby; Christine L Wohlford-Lenane; Jennifer A Bartlett; Christopher J Scott; Noel G McElvaney; Catherine M Greene; Paul B McCray; Clifford C Taggart
Journal:  Am J Respir Crit Care Med       Date:  2014-07-15       Impact factor: 21.405

7.  SPLUNC1 degradation by the cystic fibrosis mucosal environment drives airway surface liquid dehydration.

Authors:  Megan J Webster; Boris Reidel; Chong D Tan; Arunava Ghosh; Neil E Alexis; Scott H Donaldson; Mehmet Kesimer; Carla M P Ribeiro; Robert Tarran
Journal:  Eur Respir J       Date:  2018-10-04       Impact factor: 16.671

8.  Human cysteine cathepsins are not reliable markers of infection by Pseudomonas aeruginosa in cystic fibrosis.

Authors:  Clément Naudin; Alix Joulin-Giet; Gérard Couetdic; Patrick Plésiat; Aneta Szymanska; Emilia Gorna; Francis Gauthier; Franciszek Kasprzykowski; Fabien Lecaille; Gilles Lalmanach
Journal:  PLoS One       Date:  2011-09-28       Impact factor: 3.240

9.  Monocytes conditioned media stimulate fibronectin expression and spreading of inflammatory breast cancer cells in three-dimensional culture: A mechanism mediated by IL-8 signaling pathway.

Authors:  Mona M Mohamed
Journal:  Cell Commun Signal       Date:  2012-02-10       Impact factor: 5.712

10.  Evaluation of airway and circulating inflammatory biomarkers for cystic fibrosis drug development.

Authors:  Raksha Jain; Arthur Baines; Umer Khan; Brandie D Wagner; Scott D Sagel
Journal:  J Cyst Fibros       Date:  2020-07-01       Impact factor: 5.482

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.